1. Home
  2. BOOM vs SABS Comparison

BOOM vs SABS Comparison

Compare BOOM & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DMC Global Inc.

BOOM

DMC Global Inc.

HOLD

Current Price

$8.56

Market Cap

173.8M

Sector

Industrials

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$4.12

Market Cap

187.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOOM
SABS
Founded
1965
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.8M
187.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BOOM
SABS
Price
$8.56
$4.12
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$8.50
$9.80
AVG Volume (30 Days)
159.1K
370.7K
Earning Date
02-23-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$618,683,000.00
$114,698.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.46
$1.00
52 Week High
$9.92
$6.60

Technical Indicators

Market Signals
Indicator
BOOM
SABS
Relative Strength Index (RSI) 68.53 63.00
Support Level $8.30 $3.93
Resistance Level $9.20 $4.21
Average True Range (ATR) 0.37 0.28
MACD 0.09 0.02
Stochastic Oscillator 70.76 82.17

Price Performance

Historical Comparison
BOOM
SABS

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: